CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors
Condition(s):HER2-positiveLast Updated:February 15, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):HER2-positiveLast Updated:February 15, 2024Recruiting
Condition(s):MetabolismLast Updated:February 9, 2024Recruiting
Condition(s):Tobacco-Related CarcinomaLast Updated:February 8, 2024Not yet recruiting
Condition(s):PreeclampsiaLast Updated:March 28, 2024Not yet recruiting
Condition(s):Parkinson DiseaseLast Updated:March 15, 2024Completed
Condition(s):Pulmonary Embolism Subacute MassiveLast Updated:February 7, 2024Not yet recruiting
Condition(s):Cognitive DeclineLast Updated:February 7, 2024Recruiting
Condition(s):Analgesia, ObstetricalLast Updated:February 1, 2024Recruiting
Condition(s):Autonomic Nerve BlockLast Updated:January 31, 2024Recruiting
Condition(s):Colorectal CarcinomaLast Updated:January 31, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.